These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9770786)

  • 1. [The effect of surfactant therapy on the oxygen treatment of premature infants with HMD].
    Iarŭkova N
    Akush Ginekol (Sofiia); 1998; 37(1):3-5. PubMed ID: 9770786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surfactant therapy in newborns with hyaline membrane disease].
    Tsvetkova S; Chernookova V; Efremova R; Nedeva N; Bogdanova V
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():12-4. PubMed ID: 11188005
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of clinical responses to natural and synthetic surfactants.
    Rollins M; Jenkins J; Tubman R; Corkey C; Wilson D
    J Perinat Med; 1993; 21(5):341-7. PubMed ID: 8126629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neonatal intensive care resource utilization.
    Diwaker K; Roberts S; John E
    J Paediatr Child Health; 1993 Dec; 29(6):434-7. PubMed ID: 8286159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
    Narang A; Kumar P; Dutta S; Kumar R
    Indian Pediatr; 2001 Jun; 38(6):640-6. PubMed ID: 11418729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
    Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
    Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Administration of exogenous surfactant in premature very low birth weight infants with RDS].
    Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A
    Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
    Malathi I; Ng KC
    Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory mechanics before and after late artificial surfactant rescue.
    Todd DA; Choukroun ML; Fayon M; Kays C; Guénard H; Galpérine I; Demarquez JL
    J Paediatr Child Health; 1995 Dec; 31(6):532-6. PubMed ID: 8924306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosurf versus Survanta surfactant preparations: proportional-hazards regression analysis of time to successful extubation and discontinuation of oxygen therapy.
    Arnold C; Adams E; Torres E; Sidebottom R
    J Perinatol; 1996; 16(1):9-14. PubMed ID: 8869533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for retinopathy of prematurity after surfactant treatment.
    Brunner-Di Pietro D; Bossi E; Koerner F
    Eur J Pediatr; 1995; 154(9 Suppl 4):S90-4. PubMed ID: 8529721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.